Is a complete NSE/JAGSNPHARM research report available?

No complete published report is available for nse/JAGSNPHARM (NSE/JAGSNPHARM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/JAGSNPHARM stock profile: metrics, valuation and analysis

Market cap	16B
Revenue (ttm)	2.9B
Net income (ttm)	454.8M
EPS (ttm)	₹6.70
Shares out	65.9M
P/E (trailing)	36.1x
Dividend	₹2.50 (1.02%)
Volume	96,227
Beta	-0.28

All NSE/JAGSNPHARM indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

INR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,399
Employees Change	374%
Employees Change Percent	36.49
Enterprise value	INR 15B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.26
Industry PE Fwd	33.69
Isin	INE048B01035
Last refreshed	2026-09-06
Market cap	INR 16B
Price	INR 242
Price currency	INR
Rev Per Employee	2,265,574.4x
Sector	Healthcare
Sector PE	47.68
Sector PE Fwd	38.22
Sic	2833
Symbol	nse/JAGSNPHARM
Website	https://www.jagsonpal.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.85%
EV Earnings	32.94x
EV/EBIT	28.88x
EV/EBITDA	24.16x
EV/FCF	32.1x
EV/Sales	5.1x
FCF yield	2.92%
P/B ratio	5.78x
P/E ratio	36.11x
P/S ratio	5.43x
PE Ratio10 Y	25.38x
PE Ratio3 Y	33.48x
PE Ratio5 Y	34.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.65%
EBITDA Margin	21.1%
FCF margin	16.25%
Gross margin	63.9%
Gross Profit	INR 1.9B
Gross Profit Growth	3.27%
Gross Profit Growth Q	10.11%
Gross Profit Growth3 Y	8.49%
Gross Profit Growth5 Y	9.1%
Net Income	INR 454.8M
Net Income Growth	-25.24%
Net Income Growth Q	22.18%
Net Income Growth Qo Q	50.52%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	13.29%
Net Income Growth5 Y	16.29%
Pretax Margin	20.68%
Profit Margin	15.48%
Profit Per Employee	INR 350,625
Profitable Quarters	INR 33
Profitable Years	8
Roa5y	9.71
Roe5y	17.74
ROIC	21.76
Roic5y	31.62

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	34.64%
Cagr15y	31.33%
Cagr1y	0.12%
Cagr20y	19.87%
Cagr3y	14.21%
Cagr5y	35.31%
Div CAGR10	58.49%
Div CAGR3	25.99%
Div CAGR5	58.49%
EPS Growth	-26.03
EPS Growth Q	25.32
EPS Growth Qo Q	63.64
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	12.02
EPS Growth5 Y	15.47
FCF Growth	-14.79%
FCF Growth3 Y	0.23%
FCF Growth5 Y	10.95%
OCF Growth	-15.06%
OCF Growth10 Y	17.88%
OCF Growth3 Y	0.11%
OCF Growth5 Y	10.65%
Revenue Growth	3.87x
Revenue Growth Q	8.76x
Revenue Growth Qo Q	28.08x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	7.54x
Revenue Growth5 Y	6.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 1.1B
Debt	INR 81.7M
Debt EBITDA	INR 0.13
Debt Equity	INR 0.03
Debt FCF	INR 0.17
Equity	INR 2.8B
Interest Coverage	50.6
Net Cash	INR 979.6M
Net Cash By Market Cap	INR 6.14
Net Cash Growth	-18.02%
Net Debt EBITDA	INR -1.58
Net Debt Equity	INR -0.35
Net Debt FCF	INR -2.1
Tangible Book Value	INR 2B
Tangible Book Value Per Share	INR 28.28
WACC	2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	60%
Dividend Growth Years	1%
Dividend per share	INR 2.5
Dividend Years	4
Dividend Yield	1.03%
Ex Div Date	2026-09-04
Last Dividend	INR 4
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	1,856.77%
1Y total return	0.12%
200-day SMA	203.1
3Y total return	48.98%
50-day SMA	232.6
50-day SMA vs 200-day SMA	50over200
5Y total return	353.51%
All Time High	328
All Time High Change	-26.21%
All Time High Date	2024-11-29
All Time Low	2.4
All Time Low Change	9,985.83%
All Time Low Date	2008-10-27
ATR	8.36
Beta	-0.28
Beta1y	0.21
Beta2y	0.28
Ch YTD	25.67
High	243.2
High52	264.5
High52 Date	2026-06-30
High52ch	-8.48%
Low	238.8
Low52	155
Low52 Date	2026-01-22
Low52ch	56.17%
Ma50ch	4.09%
Price vs 200-day SMA	19.18%
RSI	58.35
RSI Monthly	57.82
RSI Weekly	65.58
Sharpe ratio	0.23x
Sharpe Ratio3y	0.38x
Sharpe Ratio5y	0.67x
Sortino ratio	0.53
Sortino Ratio3y	0.72
Sortino Ratio5y	1.28
Total Return	-0.05%
Tr YTD	27.78
Tr15y	5,863.55%
Tr1m	4.56%
Tr1w	2.95%
Tr3m	21.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,340,179%
Net Borrowing	-12,210,000
Shares Insiders	11.54%
Shares Institutions	1.47%
Shares Out	65,929,470
Shares Qo Q	-8.01%
Shares Yo Y	1.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	INR 438.6M
Adjusted OCF	440,070,000
Average Volume	108,001.8x
Bv Per Share	39.4
CAPEX	INR -1.5M
Ch10y	1,649
Ch15y	4,467.2
Ch1m	2.84
Ch1w	1.26
Ch1y	-2.52
Ch20y	2,625.9
Ch3m	19.84
Ch3y	43.32
Ch5y	318.6
Ch6m	47.1
Change	-0.4%
Change From Open	0.02
Close	243
Days Gap	-0.42
Depreciation Amortization	101,322,500
Dollar Volume	23,292,707.6
Earnings Date	2026-11-03
EBIT	INR 518.7M
EBITDA	INR 620M
EPS	INR 6.7
F Score	3
FCF	INR 466.6M
FCF EV Yield	3.12x
FCF Per Share	INR 7.08
Financing CF	-121,490,000
Fiscal Year End	March
Founded	1,978
Graham Number	77.08282
Graham Upside	-68.16
Income Tax	INR 152.9M
Investing CF	-356,490,000
Is Primary Listing	1
Last Earnings Date	2026-07-29
Last Report Date	2026-06-30
Last Split Date	2025-01-08
Last Split Type	Forward
Lynch Fair Value	INR 109
Lynch Upside	-54.9
Ma150	206
Ma150ch	17.52%
Ma20	235.7
Ma20ch	2.71%
Net CF	-9,860,000
Next Earnings Date	2026-11-03
Open	242
P FCF Ratio	34.2
P FCF Ratio SBC	36.39
P OCF Ratio	34.09
P OCF Ratio SBC	36.26
Payment Date	2026-10-18
Position In Range	74.37
Price Date	2026-09-04
Price EBITDA	INR 25.74
Ptbv Ratio	8.05
Relative Volume	0.9x
Revenue	2,938,450,000x
SBC By Revenue	0.98x
Share Based Comp	28,050,000
Tax By Revenue	5.2x
Tax Rate	25.16%
Tr20y	3,651.75%
Tr6m	49.57%
Volume	96,227

NSE/JAGSNPHARM (NSE/JAGSNPHARM)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/JAGSNPHARM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/JAGSNPHARM indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/JAGSNPHARM

Frequently asked questions